Search results for: Alzheimer's
Filter search results
Including Carer Quality of Life in Health Technology Evaluation: Are We There Yet?
10 March 2022
…children). For example, it is common for spouses to provide care to people with Parkinson’s and Alzheimer’s disease and for parents to provide care to children with cystic fibrosis and…
CBO Doesn’t Capture The Real Impact of H.R. 3 on Innovation
14 September 2021
…estimate will be lost due to H.R. 3 may be the 5th treatment on the market for migraines while another may be a cure for Alzheimer’s. One society may be…
H.R. 3 is the Wrong Policy for the Wrong Problem
10 September 2021
…of the high social value of spill-overs from inherently risky pharmaceutical innovation. Spending on today’s cancer therapy supports R&D for tomorrow’s cure for Alzheimer’s disease. Also, it was the “re-tooling”…
Recently published: Are Wider Societal Effects Considered in Healthcare Decision-making?
29 February 2016
…by OHE’s Martina Garau, Koonal Shah, and Adrian Towse. There is evidence suggesting that, in certain diseases areas such as Alzheimer’s disease, depression, and breast cancer, health interventions can produce…
Newly Published Analysis: Dementia: the R&D Landscape
16 November 2015
…elsewhere*. Key observations from the literature include: R&D costs are higher for neurology and Alzheimer’s disease (AD) (as well as respiratory and oncology) than other therapy areas Higher costs are…
OHE Study on Pharmaceutical R&D Costs Released
3 December 2012
…600% from the 1970s[3] to the 2000s[4]. Second, success rates for clinical development are falling as tougher therapeutic areas are tackled—e.g. neurology (Alzheimer’s), autoimmune diseases (arthritis), and oncology. Success rates…
Meeting the Challenges of Drug Development in 2022: Summary of OHE’s 50th Anniversary Conference
11 October 2012
…great unmet medical need today are very difficult to understand and to treat; for example, cancers, autoimmune diseases and neurological diseases such as Alzheimer’s. The speakers and panellists generally agreed…